A synthetic peptide for use as a blocking control in assays to test for specificity of RHAG antibody, Alternative Names: RHAG control peptide, RHAG antibody Blocking Peptide, Anti-RHAG Blocking Peptide, Rh-Associated Glycoprotein Blocking Peptide, RH2 Blocking Peptide, RH50A Blocking Peptide, Rh50 Blocking Peptide, Rh50 GP Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
RHAG
(Rh Family A Glycoprotein (RHAG))
Hintergrund
The Rh blood group antigens are associated with human erythrocyte membrane proteins of approximately 30 kDa, the so-called Rh30 polypeptides. Heterogeneously glycosylated membrane proteins of 50 and 45 kDa, the Rh50 glycoproteins, are coprecipitated with the Rh30 polypeptides on immunoprecipitation with anti-Rh-specific mono- and polyclonal antibodies. The Rh antigens appear to exist as a multisubunit complex of CD47, LW, glycophorin B, and play a critical role in the Rh50 glycoprotein.